Malpractice News: Some Prostrate Cancer Drugs of no Help for Elderly Men

Malpractice News: A study of over 20,000 Medicare patients diagnosed with prostrate cancer led researchers to question whether some of the more widely used hormone-blocking drugs prescribed to prostrate cancer patients were less effective in treating this type of cancer in elderly men.

Studies have shown that the drugs, which block the production of testosterone (which feeds cancer cells), can benefit men with more aggressive forms of the disease when used in conjunction with surgery or radiation.

The results of the study, which was published in the July 2008 edition of the Journal of the American Medical Association, indicated that men treated by drug therapy alone were slightly more likely to die of prostate cancer within six years than men who had been treated by other methods.

Our medical malpractice lawyers are here to help you.

If you have been harmed by a health professional, please complete the form below for a free medical malpractice lawsuit review. A representative of our firm will be in touch shortly.

Click To Talk To Us Online

Please complete the following questionnaire:

Name
Email
Phone Number
Best time to call
City/State
What medical procedure were you having done?
How were you injured?
How did you hear about Weitz & Luxenberg?
Additional Comments

Prostate Cancer Abiraterone Trials

Phase III Trials Stude or Prostate Cancer with new drug: Abiraterone
London reseachers publish study on Abiraterone for Prostate Cancer

Malpractice News: Prostate Cancer in Obese Men

Malpractice News: Prostate cancer diagnosed later in obese men
Malpractice News: Obese men at risk for late prostate cancer diagnosis

Malpractice News: Vision Loss and Suicide

Malpractice News: Loss of vision and poor health increase risk suicide
Malpractice News: Study on link between vision loss and suicide risks

Name

Phone

strictly confidential

Your Question